ulcerative colitis: An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
294 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
294 |
6. Filter based on genotype QC (FinnGen only) |
294 |
Control definitions (FinnGen only)
- Control exclude
- K11_IBD, K11_CHOLANGI
- Control conditions
- not K11_CHOLANGI_STRICT
and not K11_UC_STRICT
Extra metadata
- First used in FinnGen datafreeze
- DF4
Similar endpoints
↥List of similar endpoints to
Ulcerative colitis (strict) with PSC
based on the number of shared cases.
Similar with more cases:
- IBD (strict) with PSC
- Colitis, primary sclerosing
- Cholangitis (primary sclerosing, PSC), with reimbursement 202
- Cholangitis (primary sclerosing, PSC)
- Ulcerative colitis (strict definition, require KELA)
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 896 | 350 | 542 |
| Only index persons | 876 | 342 | 534 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.02 |
| Only index persons | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 26.31 | 27.84 | 25.12 |
| Only index persons | 26.07 | 27.64 | 25.07 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 294 | 136 | 158 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | 27.13 | 27.63 | 26.70 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 267
- Matched controls
- 2668
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K83.0
ICD-10 Finland
Cholangitis
+∞
323.0
267
*
A05AA02
ATC
ursodeoxycholic acid; oral
9041.3
323.0
260
7
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
+∞
323.0
267
*
A07EC02
ATC
mesalazine; oral, rectal
9009.5
323.0
258
5
K51.5
ICD-10 Finland
Left sided colitis
13589.1
291.7
225
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
+∞
277.8
267
133
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
+∞
251.5
200
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
837.6
233.2
198
9
UJF30
NOMESCO Finland
Ileoscopy through colon
82.8
163.5
183
68
UJF32
NOMESCO Finland
Coloscopy
54.6
158.3
223
226
K51.8
ICD-10 Finland
Other ulcerative colitis
+∞
122.6
108
*
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
463.9
118.3
110
*
UJK02
NOMESCO Finland
ERCP
241.8
107.2
104
7
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
32.3
101.7
141
89
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
127.7
100.0
103
13
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
+∞
99.3
89
*
L04AX01
ATC
azathioprine; systemic
64.7
95.5
109
28
WX404
NOMESCO Finland
Intravenous generell anesthesy
15.1
85.0
182
330
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
78.5
84.2
93
18
A07EA06
ATC
budesonide; oral, local oral
149.3
81.4
83
8
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
159.2
77.9
79
7
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
314.2
72.1
70
*
WX402
NOMESCO Finland
General anaesthesia
13.3
71.9
150
234
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
11.5
68.0
160
307
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
+∞
66.5
61
*
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
+∞
65.3
60
*
UJK12
NOMESCO Finland
Peroral cholangioscopy
765.2
63.6
60
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
56.4
58.2
68
16
A07EA02
ATC
hydrocortisone; rectal
229.5
55.2
55
*
P01AB01
ATC
metronidazole; oral, rectal
7.6
50.9
190
655
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
577.8
50.1
48
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.8
41.5
131
329
K50.8
ICD-10 Finland
Other Crohn disease
+∞
40.7
38
*
K50.9
ICD-10 Finland
Crohn disease, unspecified
+∞
39.6
37
*
K83.1
ICD-10 Finland
Obstruction of bile duct
156.0
38.9
40
*
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
+∞
37.4
35
*
H02AB06
ATC
prednisolone; systemic
5.5
36.9
181
742
WX002
NOMESCO Finland
Sedation and analgesia
7.2
36.9
104
217
K50.1
ICD-10 Finland
Crohn disease of large intestine
+∞
36.3
34
*
J01MA12
ATC
levofloxacin; systemic
7.3
36.2
100
202
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
396.3
35.8
35
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
8.2
35.6
89
154
TPH04
NOMESCO Finland
Cathetrisation of vein
6.5
34.6
106
244
H02AB07
ATC
prednisone; oral
8.1
33.8
84
143
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
365.1
32.6
32
*
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
365.1
32.6
32
*
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
100.3
32.6
35
*
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
+∞
31.9
30
*
ZX120
NOMESCO Finland
Intravenous
9.3
31.9
71
100
A07EC01
ATC
sulfasalazine; oral, rectal
9.4
31.7
70
97
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
13.9
31.7
56
50
K51
ICD-10 Finland
Ulcerative colitis
351.7
31.5
31
*
J01MA02
ATC
ciprofloxacin; systemic
4.8
30.7
143
515
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
312.3
28.3
28
*
K74.3
ICD-10 Finland
Primary biliary cirrhosis
161.8
28.2
29
*
K76.9
ICD-10 Finland
Liver disease, unspecified
34.4
28.0
36
12
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
60.2
27.9
32
6
JJC00
NOMESCO Finland
Allogenic transplantation of liver
+∞
27.6
26
*
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
+∞
26.5
25
*
L01BB02
ATC
mercaptopurine; oral
149.4
26.1
27
*
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
149.4
26.1
27
*
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
+∞
25.4
24
*
5761C
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]
+∞
25.4
24
*
K50.0
ICD-10 Finland
Crohn disease of small intestine
274.4
25.1
25
*
Z94.4
ICD-10 Finland
Liver transplant status
143.3
25.1
26
*
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
+∞
24.3
23
*
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
74.6
24.3
27
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
9.2
22.2
48
62
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
+∞
21.1
20
*
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
35.8
20.6
26
8
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
62.6
20.2
23
*
5561A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
+∞
20.0
19
*
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
+∞
20.0
19
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
215.1
19.8
20
*
K80.3
ICD-10 Finland
Calculus of bile duct with cholangitis
215.1
19.8
20
*
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
+∞
19.0
18
*
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
203.6
18.8
19
*
5568X
ICD-9 Finland
Idiopathic proctocolitis, Other ulcerative colitis
+∞
17.9
17
*
A07EA01
ATC
prednisolone; rectal
192.1
17.7
18
*
JJ5AT
NOMESCO Finland
NA
+∞
16.8
16
*
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
14.1
16.6
28
22
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
10.8
16.2
31
32
WX302
NOMESCO Finland
Thoracal epidural anesthesy
10.2
15.7
31
34
WX419
NOMESCO Finland
Other general anesthesy
169.4
15.6
16
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.1
15.1
50
115
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
33.9
15.0
19
6
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
84.8
14.7
16
*
K85.8
ICD-10 Finland
Other acute pancreatitis
158.2
14.6
15
*
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
10.6
14.6
28
29
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.9
14.1
117
567
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
21.5
14.0
20
10
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
25.4
14.0
19
8
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
4.4
13.9
54
146
JN4CD
NOMESCO Finland
Very extensive body CT
13.1
13.9
24
20
L04AD01
ATC
ciclosporin; systemic
11.9
13.8
25
23
127
Kela drug reimbursment
Transplant complication
11.9
13.8
25
23
C10AC01
ATC
colestyramine; oral
17.4
13.7
21
13
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
+∞
13.7
13
*
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
147.1
13.6
14
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.8
13.4
34
56
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
42.4
13.3
16
*
3AC01
NOMESCO Finland
NA
24.0
13.1
18
8
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
9.5
12.8
26
30
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
12.8
91
395
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
12.7
119
613
D94
ICPC
Chronic enteritis/ulcerative colitis
136.0
12.5
13
*
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
136.0
12.5
13
*
H02AB04
ATC
methylprednisolone; systemic
3.7
12.4
59
191
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
19.2
12.2
18
10
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.5
11.8
60
204
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
68.0
11.7
13
*
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
+∞
11.5
11
*
K92.1
ICD-10 Finland
Melaena
9.6
11.5
23
26
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
36.7
11.4
14
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.8
11.3
38
89
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
29.4
10.8
14
5
1370
FHL
Colonoscopy, whole colon
114.2
10.5
11
*
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
114.2
10.5
11
*
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
114.2
10.5
11
*
L04AA06
ATC
mycophenolic acid; systemic
9.4
10.5
21
24
JFH33
NOMESCO Finland
Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy
+∞
10.5
10
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
10.5
10
*
N02AX02
ATC
tramadol; systemic, rectal
2.5
10.4
114
621
WVA20
NOMESCO Finland
Medicine administration
9.3
10.0
20
23
UJF92
NOMESCO Finland
Capsular endoscopy
21.0
9.9
14
7
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
14.1
9.8
16
12
L04AB04
ATC
adalimumab; parenteral
9.6
9.7
19
21
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
6.5
9.5
24
40
R50.9
ICD-10 Finland
Fever, unspecified
3.2
9.4
53
193
A07DA03
ATC
loperamide; oral
11.3
9.4
17
16
K83.3
ICD-10 Finland
Fistula of bile duct
+∞
9.4
9
*
4AA12
NOMESCO Finland
NA
+∞
9.4
9
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.8
9.4
31
71
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
12.1
9.2
16
14
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
9.6
9.2
18
20
L04AC05
ATC
ustekinumab; parenteral
38.1
9.1
11
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.7
9.0
30
70
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
5.1
8.7
27
58
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
6.8
8.7
21
33
WX004
NOMESCO Finland
Patient-controlled sedation
92.8
8.5
9
*
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
+∞
8.4
8
*
JN1DM
NOMESCO Finland
Upper part of abdomen very extensive MRI examination with 3 Tesla magnet
+∞
8.4
8
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.5
8.1
15
15
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
34.5
8.1
10
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
5.0
8.1
25
54
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.7
8.0
34
100
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
46.3
7.8
9
*
UJF02
NOMESCO Finland
Peroral enteroscopy
46.3
7.8
9
*
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
46.3
7.8
9
*
L04AA01
ATC
[U] ciclosporin; systemic
10.5
7.6
14
14
JL5BM
NOMESCO Finland
Bile and pancreas ducts MRI examination with 3 Tesla magnet
82.2
7.5
8
*
Z93.2
ICD-10 Finland
Ileostomy status
82.2
7.5
8
*
A02BC01
ATC
omeprazole; systemic
2.4
7.4
69
336
1280
FHL
Endoscopic retrograde cholangiography and pancreaticography
+∞
7.3
7
*
K83
ICD-10 Finland
Other diseases of biliary tract
+∞
7.3
7
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
7.3
62
289
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
20.7
7.2
10
5
H02AB09
ATC
hydrocortisone; systemic
7.3
7.1
16
23
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
14.3
6.9
11
8
D64.9
ICD-10 Finland
Anaemia, unspecified
4.2
6.9
25
64
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.9
6.9
18
32
JFF10
NOMESCO Finland
Loop enterostomy
41.1
6.8
8
*
4AB02
NOMESCO Finland
NA
71.4
6.5
7
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
18.5
6.3
9
5
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
7.3
6.3
14
20
K83.2
ICD-10 Finland
Perforation of bile duct
+∞
6.3
6
*
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
+∞
6.3
6
*
ZXD08
NOMESCO Finland
NA
+∞
6.3
6
*
JJC60
NOMESCO Finland
Total excision of transplanted liver
+∞
6.3
6
*
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
27.4
6.3
8
*
M81.8
ICD-10 Finland
Other osteoporosis
27.4
6.3
8
*
R94.5
ICD-10 Finland
Abnormal results of liver function studies
10.4
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
198
11
549.19
307.65
2.7
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
236
57
205.80
307.65
8.5
2.8
u/ml
30.7
2493.5
0.50
221
48
(3024980) IgG subclass 4 [Mass/volume] in Serum
189
41
127.27
307.65
3.2
1.3
g/l
0.9
0.6
1.43
178
31
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
187
22
231.80
307.65
2.9
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
205
62
106.92
307.65
3.0
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
208
59
118.10
307.65
3.0
1.1
titre
66.5
72.0
—
23
5
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
259
147
140.60
307.65
9.2
4.5
ug/l
2.5
9.6
1.37
204
117
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
179
60
74.71
293.42
2.8
1.1
iu/ml
4.3
—
—
11
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
135
13
191.17
274.24
1.9
1.4
umol/l
11.3
10.2
0.42
135
13
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
142
22
123.91
272.11
1.9
1.1
titre
196.7
—
—
9
0
(3048689) Calprotectin [Mass/mass] in Stool
262
277
78.71
265.79
6.8
1.3
ug/g
178.4
72.6
7.39
251
212
(3005719) IgG [Mass/volume] in Serum or Plasma
222
172
49.62
263.46
4.6
2.4
g/l
13.0
9.7
19.19
217
161
(3022145) Colonoscopy Study observation
231
211
47.42
251.03
3.8
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
91
14
93.69
171.04
2.3
1.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
218
320
23.49
168.05
3.1
1.4
titre
532.1
382.4
0.65
86
68
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
188
252
18.92
151.90
11.7
2.1
umol/l
8.0
9.1
0.23
182
222
(3032080) INR in Blood by Coagulation assay
272
691
40.24
132.97
18.1
5.8
inr
1.0
1.1
1.50
94
218
(3042936) Bacteria identified in Isolate by Culture
168
272
13.08
113.82
2.7
1.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
215
519
12.70
102.55
3.7
1.4
g/l
2.6
2.2
3.18
208
335
(42870588) Differential panel, method unspecified - Blood
244
690
15.91
100.92
14.4
5.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
138
218
11.05
93.09
2.9
2.4
%
21.8
25.0
1.35
128
195
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
95
98
13.84
87.14
2.2
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
68
43
20.27
82.17
7.2
5.7
iu/ml
962.0
821.2
—
16
6
(3006922) Hepatitis E virus Ab [Presence] in Serum
45
14
37.77
70.83
1.1
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
207
650
8.38
70.33
3.9
2.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
44
13
39.63
70.25
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
44
13
39.63
70.25
1.1
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
183
512
7.82
69.91
5.8
3.9
ph
7.4
7.4
1.32
41
88
(3001604) Monocytes [#/volume] in Blood
262
1091
13.88
65.38
17.6
6.2
e9/l
0.5
0.6
1.17
254
964
(3013115) Eosinophils [#/volume] in Blood
267
1136
15.70
65.20
17.7
6.7
e9/l
0.2
0.2
0.51
257
1017
(3006315) Basophils [#/volume] in Blood
262
1097
13.76
64.80
17.6
6.2
e9/l
0.0
0.0
0.30
254
969
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
152
387
7.06
62.78
4.7
1.9
mg/l
3.2
3.0
0.28
141
332
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
232
885
8.69
62.01
10.2
6.8
mmol/l
1.2
1.2
0.58
205
770
(3019198) Lymphocytes [#/volume] in Blood
262
1147
12.80
60.13
17.7
6.1
e9/l
1.8
2.0
2.04
254
1026
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
217
798
7.56
59.54
9.3
6.3
mmol/l
1.2
1.2
0.01
211
732
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
40
17
27.08
56.57
4.7
2.4
%
89.4
93.9
0.20
40
17
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
187
640
6.28
54.19
5.7
2.2
u/l
70.1
55.5
1.11
181
599
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
41
21
22.53
53.81
1.4
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
266
1293
12.10
51.13
21.7
10.1
e9/l
3.5
4.0
6.39
261
1137
(3021589) Normoblasts [#/volume] in Blood
231
994
7.18
50.28
26.1
8.6
e9/l
0.0
0.0
0.55
219
815
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
32
10
35.79
49.84
5.1
2.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
209
835
6.20
49.23
3.6
1.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
52
51
12.17
48.05
1.3
1.4
u/ml
422.5
163.9
2.09
26
29
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
53
56
11.33
46.51
1.3
1.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
33
14
26.43
46.46
1.2
1.2
u/l
42.7
72.1
—
24
9
(3017143) Hepatitis C virus Ab [Presence] in Serum
132
383
5.44
44.77
1.7
1.6
—
—
—
0
0
(4035726)
83
160
6.83
43.91
1.8
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
159
547
5.15
43.60
13.4
7.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
68
116
7.32
40.26
1.4
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
52
66
9.36
39.64
1.8
1.4
iu/ml
0.0
0.1
—
18
9
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
31
17
20.27
39.18
3.7
1.4
g/l
0.8
1.1
1.12
31
17
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
143
494
4.69
37.97
1.8
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
135
452
4.67
37.21
6.8
4.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
44
50
10.17
36.38
1.3
1.6
u/ml
120.0
103.2
—
5
6
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
140
489
4.56
36.35
3.7
2.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
33
26
14.17
34.60
1.2
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
40
43
10.61
34.37
1.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
44
54
9.41
34.28
1.4
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
33
29
12.69
32.36
2.4
2.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
202
978
4.40
32.31
6.1
3.9
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
31
25
13.74
32.00
1.3
1.3
g/l
0.5
0.3
1.08
20
16
(3027135) IgG subclass 1 [Mass/volume] in Serum
31
25
13.74
32.00
1.3
1.3
g/l
10.3
6.5
2.46
21
16
(4062490)
31
25
13.74
32.00
1.3
1.5
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
31
25
13.74
32.00
1.3
1.3
g/l
3.5
2.5
1.55
20
16
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
29
21
15.21
31.80
1.1
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
67
142
5.82
31.50
6.5
6.7
%
0.0
0.0
0.49
20
42
(3017181) Myelocytes/100 leukocytes in Blood
72
165
5.45
31.02
6.5
6.1
%
0.5
1.0
0.96
25
58
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
74
174
5.35
30.96
3.2
2.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
68
149
5.64
30.79
5.9
6.0
%
0.3
0.5
0.89
19
40
(3021440) Promyelocytes/100 leukocytes in Blood
67
151
5.45
29.32
6.9
6.5
%
0.0
0.2
1.17
24
49
(3018677) aPTT in Platelet poor plasma by Coagulation assay
91
268
4.47
28.72
3.6
3.1
s
30.5
29.4
0.93
91
263
(3048929) Epstein Barr virus Ab [Presence] in Serum
56
109
6.11
28.68
1.4
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
85
241
4.55
28.13
1.4
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
58
122
5.68
27.30
4.9
3.3
mmol/l
1.2
1.2
0.96
53
111
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
33
38
9.66
26.81
1.2
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
31
7
49.28
26.08
1.1
4.7
—
—
—
0
0
(3044889) 12 lead EKG panel
246
1524
4.76
24.58
3.7
3.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
49
97
5.86
24.51
5.4
5.3
mmol/l
23.7
24.2
0.55
49
90
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
41
73
6.36
22.80
1.3
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
84
274
3.89
22.53
1.6
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
134
601
3.26
21.66
3.6
2.8
e6/l
309.8
49.6
0.42
107
460
(3030467) Casts [#/volume] in Urine by Automated count
124
539
3.25
21.01
3.7
2.7
e6/l
0.3
0.3
0.04
100
396
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
88
312
3.60
20.68
2.6
2.5
e6/l
2.1
2.4
0.22
54
166
(3024471) HLA-A [Type]
26
8
35.46
20.56
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
26
8
35.46
20.56
1.0
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
149
731
3.11
20.32
4.2
3.4
e6/l
15.7
72.3
1.26
112
492
(36304419) Bacteria [Presence] in Urine
121
529
3.19
20.15
3.7
2.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
30
44
7.48
19.92
1.4
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
57
156
4.29
19.28
2.6
2.4
ml/min/173m2
66.8
73.5
0.29
19
56
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
23
6
41.34
18.84
3.7
3.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
48
117
4.71
18.78
2.9
3.6
e9/l
68.8
76.8
0.72
34
89
(3000991) Gas panel - Venous blood
57
160
4.18
18.61
16.0
9.8
—
—
—
0
0
(3026782) Osmolality of Urine
94
370
3.26
18.47
3.1
2.5
mosm/kgh2o
557.1
570.3
0.21
86
318
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
39
83
5.26
17.86
15.2
12.9
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
35
68
5.71
17.69
1.8
2.1
g/l
1.3
1.4
0.38
30
62
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
36
72
5.56
17.65
3.1
4.4
%
213.8
166.1
2.77
36
72
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
22
7
33.80
17.29
1.1
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
22
7
33.80
17.29
1.1
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
16
0
+∞
16.83
4.7
0.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
56
169
3.86
16.44
5.4
4.7
mmol/l
1.0
1.7
0.80
48
135
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
137
703
2.78
16.31
3.7
2.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
276
2085
6.29
16.30
47.2
13.4
%
13.7
13.4
3.43
276
2051
(3000850) Epithelial cells [#/volume] in Urine
94
398
3.00
16.01
3.0
2.3
e6/l
7.1
7.0
0.01
86
347
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
83
329
3.12
15.85
2.8
2.4
e6/l
0.6
0.9
0.81
51
183
(3002256) Pathology report gross observation
67
239
3.34
15.20
1.4
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
17
18
9.96
14.46
1.4
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
33
7.13
14.23
6.7
3.6
%
52.9
57.7
0.70
22
33
(44816559) Phosphatidylethanol [Mass/volume] in Blood
33
74
4.90
14.17
1.6
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
282
2233
7.44
14.13
35.1
9.4
ml/min/173m2
94.9
91.6
1.56
260
1804
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
94
428
2.76
13.72
2.3
1.8
%
1.4
1.4
0.24
87
402
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
131
703
2.56
13.68
2.4
1.7
pmol/l
93.4
97.0
0.48
81
360
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
13
0
+∞
13.64
4.3
0.0
mg/l
3.3
—
—
13
0
(40760892) CBC W Ordered Manual Differential panel - Blood
111
557
2.60
13.26
9.6
4.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
22
39
6.02
12.14
1.0
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
84
383
2.67
12.04
2.0
1.4
nmol/l
19.2
20.4
0.38
84
331
(3030905) Polymorphonuclear cells [#/volume] in Blood
20
33
6.43
11.82
7.2
3.2
e9/l
3.6
4.1
0.45
20
33
(3025941) Bacteria identified in Stool by Culture
43
137
3.51
11.51
1.7
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
33
93
3.87
10.54
1.8
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
118
663
2.30
10.52
1.8
2.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
12
12
10.38
10.51
1.2
1.0
miu/ml
1287.2
1327.6
0.04
12
12
(3003694) ABO and Rh group [Type] in Blood
121
690
2.28
10.39
1.6
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
46
165
3.12
10.15
3.6
3.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
67
296
2.64
10.07
2.3
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
73
342
2.51
9.69
1.9
1.5
pmol/l
473.2
13115182.1
0.50
65
305
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
21
44
5.06
9.69
1.0
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
42
5.04
9.20
2.3
6.8
u/ml
0.2
0.3
—
10
25
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
22
6.63
8.60
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
278
2381
4.08
7.98
39.1
11.4
%
39.7
41.6
4.99
255
1984
(3016502) Oxygen saturation in Arterial blood
42
166
2.79
7.75
17.0
9.5
%
96.0
96.5
0.13
42
155
(3003396) Base excess in Arterial blood by calculation
45
185
2.69
7.70
16.0
8.9
mmol/l
-0.2
1.1
2.10
38
147
(3019309) Folate [Moles/volume] in Red Blood Cells
57
266
2.42
7.51
2.1
1.5
nmol/l
1370.5
1180.4
0.59
47
209
(3002173) Hemoglobin [Mass/volume] in Arterial blood
40
158
2.77
7.38
17.6
8.3
g/l
118.4
125.7
1.11
40
148
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
100
591
2.05
7.36
1.5
1.3
u/ml
1.2
1.2
0.02
23
157
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
16
7.10
7.20
2.3
1.4
pg
31.2
33.8
0.99
11
16
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
5
20.62
7.18
1.3
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
20
52
4.05
7.11
2.8
2.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
195
1477
1.95
6.71
4.9
3.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
44
193
2.51
6.59
2.3
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
15
33
4.74
6.53
3.8
3.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
44
197
2.45
6.31
2.3
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
27
94
3.06
6.23
1.9
2.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
42
188
2.44
6.02
11.0
14.4
inr
1.2
1.2
—
5
33
(3035350) Ketones [Presence] in Urine by Test strip
151
1080
1.82
5.93
3.5
3.1
estimate
0.0
0.0
0.00
45
193
(3012501) Base excess in Blood by calculation
15
36
4.34
5.89
3.6
2.5
mmol/l
1.5
2.5
—
9
25
(3003338) MCHC [Mass/volume]
260
2232
2.43
5.79
40.9
13.5
g/l
332.7
334.5
2.36
260
2223
(3009261) Glucose [Presence] in Urine by Test strip
151
1094
1.78
5.57
3.5
3.2
estimate
0.0
0.0
0.50
47
188
(3021601) Nitrite [Presence] in Urine by Test strip
149
1080
1.77
5.45
5.1
4.5
estimate
0.0
0.0
0.00
46
198
(3009871) Measles virus Ab [Titer] in Serum
8
5
16.38
5.44
1.9
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
24
86
2.95
5.28
1.8
1.5
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
5
0
+∞
5.22
1.4
0.0
mg/l
1.8
—
—
5
0
(3000494) Fungus identified in Specimen by Culture
49
250
2.15
5.17
1.9
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
13
33
4.08
4.76
3.8
2.7
%
14.3
16.9
—
6
19
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
78
484
1.83
4.70
2.3
2.2
mg/l
1.8
1.0
1.10
66
358
(3026008) Bacteria identified in Urine by Culture
79
493
1.82
4.67
2.2
2.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
16
50
3.33
4.40
2.4
1.3
—
—
—
0
0
(3015736) pH of Urine
121
870
1.66
4.26
2.6
3.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
36
3.73
4.25
1.6
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
24
98
2.58
4.17
1.5
1.3
—
2.0
—
0
5
(3007930) Methemoglobin/Hemoglobin.total in Blood
17
59
3.00
3.97
5.2
6.6
%
1.0
0.9
0.18
17
51
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
101
2.50
3.93
1.3
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
20
77
2.71
3.89
1.1
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
11
30
3.77
3.67
1.2
5.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
73
478
1.70
3.57
2.5
3.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
17
63
2.80
3.55
5.2
6.4
%
1.4
1.5
0.47
17
55
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
26
3.95
3.55
1.4
1.5
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
7
10
7.14
3.38
1.7
2.2
%
206.9
132.3
—
7
10
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
226
1958
1.67
3.37
3.5
3.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
14
5.84
3.36
1.3
1.2
—
—
—
0
0
(4281824)
9
19
4.85
3.26
1.2
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
55
2.82
3.20
2.4
2.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
90
640
1.59
3.15
3.7
2.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
19
80
2.47
3.13
1.1
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
34
3.32
3.09
1.7
1.6
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
6
8
7.63
3.07
1.7
1.6
umol/l
25.2
32.1
—
6
8
(3000093) Morphology [Interpretation] in Blood Narrative
8
17
4.81
2.94
1.4
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
18
4.54
2.81
2.6
2.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
234
0.37
2.81
3.9
5.5
—
—
—
0
0
(3004451) EKG impression Narrative
5
6
8.45
2.76
1.2
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
54
349
1.67
2.75
3.1
3.7
ng/l
24.0
336.2
2.01
40
231
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
10
6.10
2.71
1.7
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
96
716
1.51
2.65
3.4
3.1
ng/l
24.9
26.9
0.07
52
394
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
11
5.54
2.55
1.7
1.3
ug/l
13.4
8.4
—
6
11
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
11
5.54
2.55
2.0
3.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
11
5.54
2.55
2.8
2.9
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
39
2.89
2.50
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
39
2.89
2.50
1.5
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
26
3.54
2.50
1.6
1.7
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
10
34
3.01
2.43
6.3
7.8
mmol/l
106.8
105.9
—
10
26
(3039000) Anion gap in Blood
10
34
3.01
2.43
6.3
7.8
mmol/l
11.9
10.9
—
10
26
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
52
2.57
2.39
2.6
2.6
g/l
3.3
3.1
0.34
13
44
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
109
849
1.45
2.38
3.6
3.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
59
2.44
2.33
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
59
2.44
2.33
1.0
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
76
554
1.50
2.31
3.9
3.4
estimate
0.0
0.0
0.50
47
196
(42529406) Shigella sp [Presence] in Stool by Culture
17
79
2.22
2.29
1.1
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
23
3.55
2.28
1.5
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
30
3.06
2.16
2.6
2.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
24
131
1.91
2.15
1.2
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
55
0.00
2.09
0.0
5.5
—
384.3
—
0
48
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
77
2.14
2.00
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
16
77
2.14
2.00
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
27
3.02
1.95
1.9
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
20
107
1.93
1.91
1.3
1.4
miu/ml
266.3
254.5
—
10
52
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
95
1.95
1.79
2.2
2.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
24
2.96
1.73
1.7
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
24
2.96
1.73
2.0
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
24
2.96
1.73
1.9
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
35
514
0.64
1.72
4.3
3.1
kg/l
1.0
1.0
—
6
62
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
48
2.34
1.72
1.5
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
47
0.00
1.72
0.0
1.5
—
17.0
—
0
40
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
57
418
1.45
1.67
2.4
3.3
ng/l
985.4
603.7
0.36
48
339
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
257
2408
1.53
1.65
5.6
4.1
mmol/l
2.7
2.9
3.75
252
2261
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
14
3.61
1.62
2.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
27
169
1.66
1.58
4.0
4.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
33
2.46
1.55
1.9
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
33
2.46
1.55
2.3
2.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
15
3.37
1.53
1.4
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
5
15
3.37
1.53
1.0
1.4
—
8.7
—
0
6
(3045142) Bone marrow Pathology biopsy report
6
21
2.89
1.51
1.2
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
21
2.89
1.51
1.8
3.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
64
490
1.39
1.48
2.8
3.3
mg/l
27.1
500.1
1.17
38
315
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
35
497
0.66
1.47
2.7
3.6
%
21.8
22.4
—
10
173
(3013512) EKG study
66
509
1.38
1.46
3.1
3.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
16
3.16
1.44
1.2
1.3
—
—
—
0
0
(3000492) Spirometry study
38
265
1.50
1.44
1.4
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
53
2.12
1.40
2.3
2.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
17
2.97
1.36
2.2
3.4
u/ml
631.4
710.6
—
5
17
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
37
0.00
1.35
0.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
66
516
1.36
1.35
4.0
4.0
mg/mmol
3.0
8.2
1.58
43
337
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
39
0.00
1.34
0.0
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
78
627
1.33
1.33
2.8
3.0
mmol/l
8.6
8.7
0.06
72
545
(3021901) Oxygen saturation in Capillary blood
8
34
2.39
1.30
4.6
2.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
48
2.12
1.29
1.8
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
9
45
2.03
1.24
1.2
1.6
nmol/l
0.7
0.9
—
9
39
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
19
2.66
1.22
1.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
19
2.66
1.22
1.0
1.1
—
—
—
0
0
(4268621)
8
38
2.14
1.19
2.4
2.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
26
375
0.66
1.19
2.2
2.4
ug/l
1.0
0.7
0.33
12
187
(40761535) Cells panel - Urine sediment
8
155
0.50
1.17
1.4
3.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
20
2.52
1.15
1.2
1.9
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
20
2.52
1.15
2.4
2.8
mmol/l
4.0
4.0
—
5
20
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
20
2.52
1.15
2.4
2.8
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
20
2.52
1.15
2.4
2.9
mmol/l
105.8
106.0
—
5
20
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
36
0.00
1.14
0.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
41
539
0.72
1.13
1.9
2.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
31
2.29
1.11
1.1
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
37
491
0.72
1.08
1.8
2.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
52
1.96
1.07
1.8
1.6
—
—
—
0
0
(1002224) Polysomnography panel
8
147
0.53
1.07
1.0
1.0
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
7
34
2.08
1.03
4.7
3.1
mmol/l
1.3
1.5
—
7
34
(3028707) Methadone [Presence] in Urine by Screen method
5
106
0.46
1.03
1.2
2.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
47
1.94
1.03
1.2
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
23
2.19
0.98
2.2
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
23
2.19
0.98
1.2
2.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
12
69
1.77
0.98
1.2
1.2
—
3.2
—
0
9
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
36
1.97
0.97
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
205
0.62
0.91
2.3
2.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
29
2.09
0.90
1.3
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
29
2.09
0.90
1.3
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
29
2.09
0.90
1.3
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
29
2.09
0.90
1.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
29
2.09
0.90
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
29
2.09
0.90
1.3
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
42
1.93
0.89
9.1
3.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
138
0.57
0.85
1.0
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
57
1.78
0.84
1.1
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
257
0.68
0.81
1.7
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
33
252
1.35
0.81
1.4
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
28
208
1.38
0.81
1.3
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
16
230
0.68
0.75
1.4
1.9
—
—
—
0
0
(44790047)
5
24
2.10
0.75
1.8
1.5
—
—
—
0
0
(44790048)
5
24
2.10
0.75
1.8
1.5
—
—
—
0
0
(44806118)
5
24
2.10
0.75
1.8
1.5
—
—
—
0
0
(44790049)
5
24
2.10
0.75
1.8
1.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
55
1.66
0.74
1.1
1.2
—
1.0
—
0
5
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
38
1.86
0.74
1.6
1.7
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
25
2.02
0.73
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.02
0.73
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
25
2.02
0.73
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
26
1.94
0.71
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
26
1.94
0.71
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
26
1.94
0.71
1.2
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
238
0.70
0.71
1.1
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
186
1743
1.18
0.69
4.4
3.7
pmol/l
14.5
14.6
0.21
172
1617
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
27
1.87
0.68
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
27
1.87
0.68
1.2
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
78
1.56
0.66
2.3
2.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
44
1.61
0.65
4.6
3.7
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
5
29
1.74
0.64
5.8
3.5
mmol/l
7.4
7.8
—
5
29
(3009214) Lutropin [Units/volume] in Serum or Plasma
15
104
1.47
0.64
1.5
1.5
u/l
5.6
7.8
—
10
90
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
186
0.68
0.62
1.4
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
17
231
0.72
0.61
1.4
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
17
231
0.72
0.61
1.4
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
22
166
1.35
0.60
1.2
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
20
0.00
0.60
0.0
2.7
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
29
362
0.78
0.59
1.7
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
81
1.50
0.58
3.7
3.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
16
217
0.72
0.57
1.4
1.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
17
228
0.73
0.57
1.4
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
36
1.68
0.57
1.3
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
73
1.53
0.57
2.2
1.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
33
403
0.80
0.57
1.3
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
6
37
1.63
0.56
11.8
2.8
%
50.8
65.5
—
6
37
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
13
91
1.45
0.54
1.8
1.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
17
126
1.37
0.53
3.9
4.1
mmol/l
0.8
1.4
—
8
94
(4010399)
11
156
0.69
0.51
1.4
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
20
252
0.78
0.45
2.1
2.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
220
2121
1.15
0.44
4.7
4.3
mu/l
2.0
2.4
0.32
208
1970
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.0
—
0
5
(3009343) pH of Capillary blood
17
132
1.31
0.41
3.9
4.0
ph
7.4
7.4
—
5
16
(3020874) Milk IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
0.1
—
0
8
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
0.3
—
0
5
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.1
—
1.2
—
0
8
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
36
1.40
0.38
1.2
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
41
1.47
0.36
1.0
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
47
1.28
0.32
1.7
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
55
606
0.89
0.31
1.7
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
11
142
0.77
0.31
1.4
2.2
ug/l
1.8
8.3
2.55
11
133
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
100
0.69
0.31
1.6
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
13
102
1.29
0.30
5.1
5.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
163
0.79
0.30
1.5
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
83
0.72
0.24
1.3
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
84
0.71
0.24
2.0
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
22
190
1.17
0.24
1.0
1.3
iu/ml
76.6
170.6
—
5
76
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
38
1.32
0.23
1.4
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
91
0.76
0.23
1.4
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
91
0.76
0.23
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
92
0.76
0.23
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
92
0.76
0.23
1.4
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
98
1030
0.93
0.22
4.1
2.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
18
154
1.18
0.21
1.6
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
12
98
1.23
0.21
3.8
3.1
ng/l
117.4
128.8
0.08
12
85
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
24.4
—
0
11
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.3
—
441.4
—
0
11
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
5.8
—
0
13
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
205
2090
0.94
0.17
6.4
4.6
mmol/mol
37.3
38.5
0.83
198
1980
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
43
399
1.09
0.17
1.2
1.3
iu/ml
20.9
25.4
0.20
14
120
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
71
1.13
0.16
1.4
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
77
0.77
0.16
1.5
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
96
0.83
0.14
1.6
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
14
158
0.88
0.12
1.3
2.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
32
339
0.94
0.09
1.2
1.6
—
—
—
0
0
(4094501)
6
54
1.11
0.09
1.0
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
65
0.77
0.08
2.8
1.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
104
0.86
0.06
1.3
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
129
1.09
0.05
3.6
2.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
129
1.09
0.05
1.0
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
222
2233
0.98
0.04
3.7
3.7
mmol/l
5.8
5.8
0.26
216
2075
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
40
392
1.02
0.01
1.3
1.3
u/ml
1.3
7.2
2.19
13
156
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
39
383
1.02
0.01
1.4
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
36
354
1.02
0.00
1.6
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
141
0.99
0.00
1.9
1.8
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
65
0.92
0.00
1.2
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
54
0.92
0.00
1.4
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
106.8
—
0
5
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
69
0.87
0.00
1.0
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
12.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
72
0.97
0.00
1.4
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
4.5
—
0
5
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4034850)
7
74
0.94
0.00
6.0
7.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
43.8
—
0
6
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4024509)
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(4038314)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
76
0.92
0.00
1.4
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
73
0.96
0.00
1.4
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
53
0.94
0.00
1.4
1.2
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
5
0.00
0.00
0.0
1.6
—
85.8
—
0
5
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
16.9
—
0
7
(3022313) Gas panel - Capillary blood
9
97
0.93
0.00
3.3
4.1
—
—
—
0
0
(4015189)
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
2.4
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint K11_UC_STRICT_PSC and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have K11_UC_STRICT_PSC.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: K11_UC_STRICT_PSC – Ulcerative colitis (strict) with PSC
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data